BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34022224)

  • 1. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
    Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
    Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing.
    Dong Q; Li X; Wang CZ; Xu S; Yuan G; Shao W; Liu B; Zheng Y; Wang H; Lei X; Zhang Z; Zhu B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4013-E4022. PubMed ID: 29636421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
    Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
    Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
    Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
    Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
    Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
    Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
    Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
    J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
    Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
    Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
    Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
    Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.
    Romero-Pérez L; Garcia-Sanz P; Mota A; Leskelä S; Hergueta-Redondo M; Díaz-Martín J; López-García MA; Castilla MA; Martínez-Ramírez A; Soslow RA; Matias-Guiu X; Moreno-Bueno G; Palacios J
    Mod Pathol; 2015 Nov; 28(11):1492-503. PubMed ID: 26381823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-based screening for TAZ activators identifies ethacridine, a widely used antiseptic and abortifacient, as a compound that promotes dephosphorylation of TAZ and inhibits adipogenesis in C3H10T1/2 cells.
    Kawano S; Maruyama J; Nagashima S; Inami K; Qiu W; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
    J Biochem; 2015 Nov; 158(5):413-23. PubMed ID: 25979969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
    Jiang MC
    Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
    Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
    FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSE1L promotes proliferation and migration in oral cancer through positively regulating MITF.
    Wang YS; Peng C; Guo Y; Li Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5429-5435. PubMed ID: 32495878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of TAZ in cancer.
    Zhou X; Lei QY
    Protein Cell; 2016 Aug; 7(8):548-61. PubMed ID: 27412635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
    Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
    Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSE1L/CAS: its role in proliferation and apoptosis.
    Behrens P; Brinkmann U; Wellmann A
    Apoptosis; 2003 Jan; 8(1):39-44. PubMed ID: 12510150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
    J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.